Altogether, 309 cases of DLBCL and 22 cases of HGBL (either NOS or with MYC and BCL2 and/or BCL6 rearrangements) were diagnosed in the period from 2017 to 2021 at the IOL. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.